Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
known for big swings, another big swing in store here in coming weeks with this micro floater,
lets see 2 and build it up as we await for milestone
nice eod action, known for large swings, with the milestone event in june,, will see large pops ahead ,,,,,,,
strong, reversal starting
nice eod hits, we see volume it goes as we await for milestone event
not getting that fire power volume, slow reversal
had to average down here. offerings bs is how it works with bigboard biotechs. they all do it, yet run big on events, pending big event in june, hold for events with 4m OS,, hence big swings before
best to buy them in wedge chart an wait for events
ran t0 1.93 like butter, was nice comeback friday with nice action, event in june
was crucial for a comeback on friday
with this buying pressure we saw friday if it contiues can see 2
going over my 40 biotech watchlist, the offerings are everyday practice on Nasdaq imo our milestone event will be worth the wait
got loaded today, we see some action next week it goes, been a bumpy sick ride, usually i sell at loss, with big board bio techs, hold for events
nailed bottom, want to see volume pick up from here, consider offerings as a way to buy cheap shares
its starting, can see 2.00 today or by friday
the run to 3.84 was for good reason ,, want to see volume pick up, up from here its peers did big pops. this will to in coming weeks with this rare tiny market cap
I bought more,I'm loaded
was a good double up, with EPS at 2.37 hence last pop to 3.84 on that PR. selling on offering is dumb in bigboard biotech, double up and wait ,,,
doubled up here, june is when phase 3 starts. will get that big pop in coming weeks
wired money to average all the way down
EPS 2.27 SO THAT is why it run to 3.84 on news, they run on milestones. start of phase 3, this bs offering gives me chance to buy. at lower prices. and in coming weeks, it goes again
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172003902
always sold at loss in the offerings and it runs big in coming weeks, trick is load up on dips and wait for it to unfold in coming weeks
Dermata Therapeutics GAAP EPS of -$2.27
May 11, 2023 5:44 PM ETDermata Therapeutics, Inc. (DRMA)By: Gaurav Batavia, SA News Editor
Dermata Therapeutics press release (NASDAQ:DRMA): Q1 GAAP EPS of -$2.27.
As of March 31, 2023, Dermata had $8.8 million in cash and cash equivalents, compared to $6.2 million as of December 31, 2022.
https://seekingalpha.com/news/3970562-dermata-therapeutics-gaap-eps-of-2_27?utm_source=otcmarkets&utm_medium=referral
The gross proceeds to the Company from the registered direct offering and the concurrent private placement were approximately $1.8 million, before deducting the placement agent's fees and other offering expenses payable by the Company. The Company intends to use the net proceeds for general corporate purposes, which includes, without limitation, ongoing research and pre-clinical studies, clinical trials, the development of new biological and pharmaceutical technologies, investing in or acquiring companies that are synergistic with or complementary to our technologies, licensing activities related to our current and future product candidates, and to the development of emerging technologies, investing in or acquiring companies that are developing emerging technologies, licensing activities, or the acquisition of other businesses and working capital.
https://finance.yahoo.com/news/dermata-therapeutics-announces-closing-1-200000286.html
A good read, Price should be much higher. In my opinion. Give it a little time.
the sky is falling
this dilution was uncalled for
You hold and wait, you'll mise a good portion of the profit. imo.
Currently, Dermata has a Zacks Rank #3 (Hold).
Some better-ranked stocks for investors interested in the same sector are CRISPR Therapeutics CRSP, Kala Pharmaceuticals KALA and Allogene Therapeutics ALLO, each carrying a Zacks Rank #2 (Buy)
phase 2 topline results hence pop from .98 to 3.93. under 5m marketcap while its peers have large marketcaps, balance sheet looks good, this small offering dont scare me its not the end of world folks, will average down next week
I think this one is a sleeper, When it wakes up this will be a good place to be. phase 3 begins, volume and price should pick up. IMO.
phase 3 trials start in june
those fucking offerings are strange, always sold. at loss. best to hold it out and wait
they claimed the offering to raise 5m 2 months ago was able to fund operations into 2024, guess not.......
phase 3 trials start it pops
hit with fucking offering for 800k
hit with fucking offering for 800k
DRMA: THANKS, Capt. N-S!!!
Followers
|
5
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
258
|
Created
|
08/30/21
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |